54095-5 |
Chemotherapy effectiveness panel |
Prid |
Bld/Tiss |
- |
Doc |
|
|
ACTIVE |
Chemotherapy effectiveness panel [Identifier] - Blood or Tissue |
|
MIN |
DefinitionDescription |
|
|
|
Sensitive, Intermediate, Resistant |
|
|
|
|
|
PANEL.DRUG/TOX |
|
54095-5 |
|
|
|
|
|
|
|
|
0 |
Chemotherapy effectiveness Pnl Bld/T |
|
|
|
N |
|
Blood; Chemo; Chemotherapy effectiveness Pnl; Document; DRUG/TOXICOLOGY; Drugs; Identity or presence; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue |
2.63 |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
0 |
54096-3 |
Identity testing |
Prid |
Index case^Comparison case |
Pt |
Nar |
Molgen |
|
ACTIVE |
Identity testing [Identifier] in Index case from Comparison case by Molecular genetics method Narrative |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MOLPATH |
|
54096-3 |
|
Molgen |
|
|
Both |
|
|
|
0 |
Identity testing Index Compar |
|
|
|
N |
|
Compare; Identity or presence; Molecular genetics; Molecular pathology; MOLPATH; Narrative; Paternity testing; PCR; Point in time; Random; Report |
2.36 |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
0 |
54097-1 |
Organophosphonate nerve agent metabolite panel |
MCnc |
Urine |
Pt |
- |
|
|
ACTIVE |
Organophosphonate nerve agent metabolite panel [Mass/volume] - Urine |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.DRUG/TOX |
|
54097-1 |
|
|
|
|
Order |
|
|
|
0 |
OP nerve agent metab Pnl Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Metab; Metabolites; Metb; OP nerve agent metab Pnl; Pan; PANEL.DRUG & TOXICOLOGY; Panl; Pnl; Point in time; Random; UA; UR; Urn |
2.71 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
54098-9 |
Isopropyl methylphosphonate |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Isopropyl methylphosphonate [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
DRUG/TOX |
|
54098-9 |
|
|
|
|
Both |
|
|
|
0 |
IMPA Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; IMPA; Level; Mass concentration; MeP; Methyl phosphonate; Methyl phosphonic acid; Methylphosphonic acid; MP; MPA; MPn; Point in time; QNT; Quan; Quant; Quantitative; Random; Sarin metabolite; UA; UR; Urn |
2.42 |
2.26 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
54099-7 |
1,2,2-Trimethylpropyl methylphosphonate |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
1,2,2-Trimethylpropyl methylphosphonate [Mass/volume] in Urine |
|
NAM |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
DRUG/TOX |
|
54099-7 |
|
|
|
|
Both |
|
|
|
0 |
TMPA Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; i; II; Level; Mass concentration; MeP; Methyl phosphonate; Methyl phosphonic acid; Methylphosphonic acid; MP; MPA; MPn; Point in time; QNT; Quan; Quant; Quantitative; Random; TMPA; UA; UR; Urn |
2.56 |
2.26 |
|
|
|
|
|
|
|
pg/mL |
|
|
Changed Component 1, 2 ,2-Trimethylpropyl methylphosphonate (removed spaces) to 1,2,2-Trimethylpropyl methylphosphonate, to fit the current LOINC model. |
0 |
541-3 |
Mycobacterium sp |
Prid |
Urine |
Pt |
Nom |
Organism specific culture |
|
ACTIVE |
Mycobacterium sp identified in Urine by Organism specific culture |
|
NAM |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
541-3 |
|
Organism specific culture |
|
|
Both |
|
|
|
0 |
Mycobacterium Ur Cult |
|
|
|
|
|
Acid Fast; Acid Fast Bacilli; Acid fast bacillus; AFB; C&S; Cult; Cultures; ID; Identity or presence; Infectious Disease; InfectiousDisease; Microbiology; Myco; Mycobact; Nominal; Point in time; Random; Spec; species; spp; Tuberculosis; UA; UR; Urn |
2.78 |
1 |
|
|
|
|
|
|
|
|
|
|
Release 2.78: COMPONENT: Removed "Identified" from the component because it is implied by the Property "Prid"; |
0 |
5410-6 |
Yersinia pseudotuberculosis Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Yersinia pseudotuberculosis Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5410-6 |
|
|
|
|
Both |
|
|
|
0 |
Y pseudoTB Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR; Y pseudoTB; Y pseudotuberculosis |
2.73 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
54100-3 |
Monocyclohexyl methylphosphonate |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Monocyclohexyl methylphosphonate [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
DRUG/TOX |
|
54100-3 |
|
|
|
|
Both |
|
|
|
0 |
Monocyclohexyl Me-phosphonate Ur-mCnc |
|
|
|
N |
|
Cyclosarin metabolite; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MeP; Methyl phosphonate; Methyl phosphonic acid; Methylphosphonic acid; Monocyclohexyl Me-phosphonate; MP; MPA; MPn; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn |
2.56 |
2.26 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
54101-1 |
2-Methylpropyl methylphosphonate |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
2-Methylpropyl methylphosphonate [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
DRUG/TOX |
|
54101-1 |
|
|
|
|
Both |
|
|
|
0 |
VX acid Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; II; Level; Mass concentration; MeP; Methyl phosphonate; Methyl phosphonic acid; Methylphosphonic acid; MP; MPA; MPn; Nerve agent metabolite; Point in time; QNT; Quan; Quant; Quantitative; Random; UA; UR; Urn; VX acid; VX metabolite |
2.56 |
2.26 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
54102-9 |
Monoethyl methylphosphonate |
MCnc |
Urine |
Pt |
Qn |
|
|
ACTIVE |
Monoethyl methylphosphonate [Mass/volume] in Urine |
|
MIN |
DefinitionDescription |
|
|
pg/mL |
|
|
|
|
|
|
DRUG/TOX |
|
54102-9 |
|
|
|
|
Both |
|
|
|
0 |
Monoethyl Me-phosphonate Ur-mCnc |
|
|
|
N |
|
DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; MeP; Methyl phosphonate; Methyl phosphonic acid; Methylphosphonic acid; Monoethyl Me-phosphonate; MP; MPA; MPn; Point in time; QNT; Quan; Quant; Quantitative; Random; Russian VX acid; UA; UR; Urn; VX metabolite |
2.56 |
2.26 |
|
|
|
|
|
|
|
pg/mL |
|
|
|
0 |
54103-7 |
Hemoglobin pattern |
Find |
Bld.dot |
Pt |
Nom |
Electrophoresis |
|
DISCOURAGED |
Hemoglobin pattern in DBS by Electrophoresis |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
54103-7 |
|
Electrophoresis |
|
|
Observation |
|
|
|
0 |
Hgb Fract DBS Elph |
|
|
|
N |
|
Blood; DBS; Dried blood spot; Elec; Elect; Electr; Electro; Electrophhrs; Electrophrs; Elp; Elph; Ep; Filter paper; Finding; Findings; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; Nominal; Point in time; Random; WB; Whole blood |
2.65 |
2.26 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54104-5 |
Hemoglobin pattern |
Find |
Bld.dot |
Pt |
Nom |
HPLC |
|
DISCOURAGED |
Hemoglobin pattern in DBS by HPLC |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
54104-5 |
|
HPLC |
|
|
Observation |
|
|
|
0 |
Hgb Fract DBS HPLC |
|
|
|
N |
|
Blood; DBS; Dried blood spot; Filter paper; Finding; Findings; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; High performance liquid chromatography; High pressure liquid chromatography; Nominal; Point in time; Random; WB; Whole blood |
2.73 |
2.26 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54105-2 |
Hemoglobin pattern |
Find |
Bld.dot |
Pt |
Nom |
Isoelectric focusing |
|
DISCOURAGED |
Hemoglobin pattern in DBS by Isoelectric focusing |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
HEM/BC |
|
54105-2 |
|
Isoelectric focusing |
|
|
Observation |
|
|
|
0 |
Hgb Fract DBS IEF |
|
|
|
N |
|
Blood; DBS; Dried blood spot; Filter paper; Finding; Findings; FP; Haemoglobin; Hb; HEMATOLOGY/CELL COUNTS; Hgb; Hgb Fract; IEF; Nominal; Point in time; Random; WB; Whole blood |
2.73 |
2.26 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54106-0 |
Newborn hearing screen method |
Type |
Ear |
Pt |
Nom |
|
|
ACTIVE |
Newborn hearing screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
H&P.HX |
|
54106-0 |
|
|
|
|
Observation |
|
|
|
0 |
NB hearing scn meth |
|
|
|
N |
|
H+P; H+P.HX; Hearing; Meth; Method of; NB hearing; NB hearing scn; NB hearing scn meth; NBS; New born; Nominal; Otologic; P prime; Point in time; Random; Scn; Scn Meth; Scr; Scrn; Typ |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Preferred" to fit the current LOINC model. |
0 |
54107-8 |
Newborn hearing screen |
Arb |
Ear.bilateral |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Newborn hearing screen - bilateral |
|
DEL |
DefinitionDescription |
|
|
|
Pass/Refer |
|
|
|
|
|
H&P.HX |
|
54107-8 |
|
|
|
|
Both |
|
|
|
0 |
Deprecated NB hearing scn -BL |
|
|
|
N |
|
Arbitrary; Bil; Bilat; Both; Ear-Bl; H+P; H+P.HX; Hearing; NB hearing; NB hearing scn; NBS; New born; Ordinal; Otologic; P prime; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.36 |
2.26 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54108-6 |
Newborn hearing screen |
Arb |
Ear.left |
Pt |
Ord |
|
|
ACTIVE |
Newborn hearing screen of Ear - left |
|
MIN |
DefinitionDescription |
|
|
|
Pass/Refer |
|
|
|
|
|
H&P.HX |
|
54108-6 |
|
|
|
|
Both |
|
|
|
0 |
NB hearing scn Ear-L |
|
|
|
N |
|
Arbitrary; Audiology; Ear-L; H+P; H+P.HX; Hearing; L; LT; NB hearing; NB hearing scn; NBS; New born; Ordinal; Otologic; P prime; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Preferred" to fit the current LOINC model. |
0 |
54109-4 |
Newborn hearing screen |
Arb |
Ear.right |
Pt |
Ord |
|
|
ACTIVE |
Newborn hearing screen of Ear - right |
|
MIN |
DefinitionDescription |
|
|
|
Pass/Refer |
|
|
|
|
|
H&P.HX |
|
54109-4 |
|
|
|
|
Both |
|
|
|
0 |
NB hearing scn Ear-R |
|
|
|
N |
|
Arbitrary; Audiology; Ear-R; H+P; H+P.HX; Hearing; NB hearing; NB hearing scn; NBS; New born; Ordinal; Otologic; P prime; Point in time; QL; Qual; Qualitative; R; Random; RT; Scn; Scr; Screen; Scrn |
2.73 |
2.26 |
|
|
|
|
|
|
|
|
|
|
Changed answer list from "Normative" to "Preferred" to fit the current LOINC model. |
0 |
5411-4 |
Yersinia sp Ab |
ACnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Yersinia sp Ab [Units/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
5411-4 |
|
|
|
|
Both |
|
|
|
0 |
Yersinia Ab Ser-aCnc |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Arbitrary concentration; Autoantibodies; Autoantibody; ID; Infectious Disease; InfectiousDisease; Microbiology; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; species; spp; SR |
2.69 |
1 |
|
|
|
|
|
|
|
[arb'U]/mL |
|
|
|
0 |
54110-2 |
Newborn hearing screen |
Arb |
Ear |
Pt |
Ord |
|
|
DEPRECATED |
Deprecated Newborn hearing screen |
|
DEL |
DefinitionDescription |
|
|
|
Pass/Refer |
|
|
|
|
|
H&P.HX |
|
54110-2 |
|
|
|
|
Both |
|
|
|
0 |
DeprecatedNewborn hearing screen |
|
|
|
N |
|
Arbitrary; H+P; H+P.HX; Hearing; NB hearing; NB hearing scn; NBS; New born; Ordinal; Otologic; P prime; Point in time; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn |
2.36 |
2.26 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
54111-0 |
Newborn hearing screening panel |
- |
^Patient |
Pt |
- |
|
|
ACTIVE |
Newborn hearing screening panel |
|
PANEL |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.H&P |
|
54111-0 |
|
|
|
|
Order |
|
|
|
0 |
NB hear screen Pnl |
|
|
|
N |
|
Asympt; Asymptomatic; Audiology; H+P; NB hear screen; NB hear screen Pnl; NB hearing; New born; P prime; Pan; PANEL.H&P; Panl; Pnl; Point in time; Random; Scn |
2.77 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
Panel contains observations relevant to the screening itself, not necessarily to hearing loss. |
0 |
54112-8 |
Cause of death |
Find |
^Family member |
Pt |
Nom |
USSG-FHT |
|
ACTIVE |
Cause of death Family member [USSG-FHT] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.USSGFHT |
|
54112-8 |
|
USSG-FHT |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Fam Mem; FHH; Finding; Findings; Nominal; Point in time; Random; Survey; SURVEY.USSGFHT; US Surgeon General; US Surgeon General family health portrait |
2.44 |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
0 |
54113-6 |
Age range at death |
Type |
^Family member |
Pt |
Nom |
USSG-FHT |
|
ACTIVE |
Age range at death Family member [USSG-FHT] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.USSGFHT |
|
54113-6 |
|
USSG-FHT |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Fam Mem; FHH; Nominal; Point in time; Random; Rnge; Survey; SURVEY.USSGFHT; Typ; US Surgeon General; US Surgeon General family health portrait |
2.44 |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
0 |
54114-4 |
Family member health history |
- |
^Family member |
Pt |
- |
USSG-FHT |
|
ACTIVE |
Family member health history [USSG-FHT] Family member |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.SURVEY.USSGFHT |
|
54114-4 |
|
USSG-FHT |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Fam Mem; Family member health Hx; FHH; Hx; Pan; Panel; Panl; Pnl; Point in time; Random; Survey; SURVEY.USSGFHT; US Surgeon General; US Surgeon General family health portrait; USSGFHT |
2.44 |
2.26 |
|
Panel |
|
|
|
|
|
|
|
|
|
0 |
54115-1 |
Age range at onset of disease |
Type |
^Family member |
Pt |
Nom |
USSG-FHT |
|
ACTIVE |
Age range at onset of disease Family member [USSG-FHT] |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.USSGFHT |
|
54115-1 |
|
USSG-FHT |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Dis; Diseases; Dz; Fam Mem; FHH; Nominal; Point in time; Random; Rnge; Survey; SURVEY.USSGFHT; Typ; US Surgeon General; US Surgeon General family health portrait |
2.44 |
2.26 |
|
|
|
|
|
|
|
|
|
|
|
0 |
54116-9 |
History of diseases |
Hx |
^Family member |
Pt |
Nom |
USSG-FHT |
|
ACTIVE |
History of diseases Family member [USSG-FHT] |
|
MAJ |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
SURVEY.USSGFHT |
|
54116-9 |
|
USSG-FHT |
|
|
|
|
|
|
0 |
|
|
|
|
N |
|
Diseases Hx; Fam Mem; FHH; H/O; History; Hx; Nominal; Point in time; Random; Survey; SURVEY.USSGFHT; US Surgeon General; US Surgeon General family health portrait |
2.56 |
2.26 |
|
|
|
|
|
|
|
|
|
|
Changed Property from "Find" to "Hx" per 8/2015 Clinical LOINC Committee decision |
0 |